Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hydration Pharmaceuticals Co. Ltd. ( (AU:HPC) ) has issued an announcement.
Hydration Pharmaceuticals Co. Ltd. announced the completion of its Rights Issue, which offered 1 new share for every 5 existing shares at $0.01 per share. The Rights Issue, combined with a Placement, raised a total of $650,000 before costs. With 13,387,853 new shares accepted, a significant shortfall of 47,594,949 shares remains, which the company may place within three months. This capital raising effort is expected to impact the company’s financial positioning and shareholder value.
More about Hydration Pharmaceuticals Co. Ltd.
Hydration Pharmaceuticals Co. Ltd., trading as Hydralyte USA, operates in the hydration solutions industry, focusing on providing products that address hydration needs. The company is listed on the Australian Securities Exchange under the ticker ASX: HPC.
YTD Price Performance: -45.00%
Average Trading Volume: 510,878
Technical Sentiment Signal: Buy
For detailed information about HPC stock, go to TipRanks’ Stock Analysis page.